Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT03195673

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03195673
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03195673. Randomized; double masking; primary purpose prevention. Start 2018-03-02 (actual); primary completion 2019-11-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting
Acronym
TZ-CAS
Condition
Carotid Artery Stenosis
Intervention (Drug)
Terazosin
Intervention (Procedure)
Carotid artery stenting
Lead sponsor
Capital Medical University (class: other)
Collaborator
The Luhe Teaching Hospital of the Capital Medical University (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct03195673
Content hash
6c480193a0527483601b7aa8be408dacc4a5353f453aa15c7100b8864ccf7c21